Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nevus Eye”

304 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 304 results

Testing effectiveness (Phase 2)UnknownNCT02913417
What this trial is testing

Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases

Who this might be right for
Uveal MelanomaHepatic Metastases
David Minor, MD 26
Large-scale testing (Phase 3)Study completedNCT02678572
What this trial is testing

Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma

Who this might be right for
Melanoma, Ocular
Delcath Systems Inc. 102
Early research (Phase 1)Study completedNCT01665183
What this trial is testing

Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma

Who this might be right for
Cutaneous Melanoma, Uveal Melanoma, Ovarian Carcinoma or Other Advanced Solid Tumors
Polaris Group 8
Early research (Phase 1)Ended earlyNCT05047536
What this trial is testing

KZR-261 in Subjects With Advanced Solid Malignancies

Who this might be right for
Advanced/Metastatic Solid Tumor
Kezar Life Sciences, Inc. 61
Early research (Phase 1)Active Not RecruitingNCT04328844
What this trial is testing

Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

Who this might be right for
Solid Tumor, AdultNon-Hodgkin Lymphoma, AdultNSCLC+2 more
iOnctura 210
Testing effectiveness (Phase 2)Active Not RecruitingNCT04728633
What this trial is testing

Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the LiverMetastatic Uveal MelanomaStage IV Choroidal and Ciliary Body Melanoma AJCC V8
Thomas Jefferson University 28
Large-scale testing (Phase 3)Looking for participantsNCT06581406
What this trial is testing

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal Melanoma
Replimune, Inc. 280
Not applicableUnknownNCT00406900
What this trial is testing

Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma

Who this might be right for
MelanomaRadiotherapyMetastatic Disease
Ludwig-Maximilians - University of Munich 560
Not applicableLooking for participantsNCT07421739
What this trial is testing

Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects

Who this might be right for
Choroidal MelanomaIndeterminate LesionsUveal Melanoma+1 more
Aura Biosciences 15
Post-approval studies (Phase 4)UnknownNCT02379000
What this trial is testing

TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy

Who this might be right for
Exudative Retinal DetachmentUveal Melanoma
Charite University, Berlin, Germany 50
Not applicableNo Longer AvailableNCT01728051
What this trial is testing

Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver

Who this might be right for
Metastatic Liver CancerOcular MelanomaCutaneous Melanoma
Delcath Systems Inc.
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Not applicableEnrolling By InvitationNCT06330324
What this trial is testing

Reproductive Options in Inherited Skin Diseases

Who this might be right for
IchthyosisPalmoplantar KeratosesEpidermolysis Bullosa+7 more
Maastricht University Medical Center 650
Testing effectiveness (Phase 2)Looking for participantsNCT05524935
What this trial is testing

Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma

Who this might be right for
Uveal MelanomaOcular Melanoma
H. Lee Moffitt Cancer Center and Research Institute 37
Not applicableStudy completedNCT04118062
What this trial is testing

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

Who this might be right for
Metastatic Uveal MelanomaTriple Negative Breast CancerLuminal B Breast Cancer+1 more
Institut Curie 128
Not applicableStudy completedNCT04577742
What this trial is testing

Uveal Melanoma and Brachytheraphy: Long-term Outcomes.

Who this might be right for
106 Ruthenium Plaque BrachytherapyUveal Melanoma
Federico II University 350
Early research (Phase 1)Looking for participantsNCT03025256
What this trial is testing

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

Who this might be right for
Acral Lentiginous MelanomaCentral Nervous System MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8+7 more
M.D. Anderson Cancer Center 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT05907954
What this trial is testing

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

Who this might be right for
Uveal Melanoma
IDEAYA Biosciences 160
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Active Not RecruitingNCT05987332
What this trial is testing

IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal Melanoma
IDEAYA Biosciences 420
Load More Results